Junqi Niu | Clinical Medicine | Best Researcher Award

Prof Junqi Niu | Clinical Medicine | Best Researcher Award

Professor, First hospital of Jilin University, China

Niu Junqi is a distinguished professor and chief of the Department of Infectious Diseases at the First Hospital of Jilin University, China. With extensive experience in hepatology, his research focuses on Hepatitis B, Hepatitis C, liver fibrosis, and hepatocellular carcinoma. He has contributed significantly to the epidemiology and therapeutic clinical trials of chronic liver diseases. Over the years, he has held esteemed positions, including Vice President of the First Hospital at Jilin University. His work has earned him numerous national and provincial recognitions. With a prolific academic record, he has authored over 180 publications and accumulated thousands of citations. He continues to lead pioneering research in liver disease treatments, making substantial contributions to the medical field.

PROFESSIONAL PROFILE

Scopus

EDUCATION πŸŽ“

  • M.D. (1978-1982): Jilin Medical College, Jilin, China
  • M.S. (1985-1988): Norman Bethune University of Medical Sciences, Changchun, China
  • Ph.D. (1996-2000): Norman Bethune University of Medical Sciences, Changchun, China

EXPERIENCE πŸ’Ό

  • 1988-1992: Assistant Professor & Physician, Norman Bethune University of Medical Sciences
  • 1992-1994: Visiting Fellow, Dept. of Medicine, St. Mary’s Hospital, Imperial College London, UK
  • 1994-1997: Associate Professor & Consultant Physician, Dept. of Infectious Diseases, Norman Bethune University of Medical Sciences
  • 1997-1999: Senior Visiting Fellow, University of Connecticut Health Center, USA
  • 1999-Present: Professor & Chief, Dept. of Infectious Diseases, First Hospital, Jilin University
  • 2001-2012: Vice President, First Hospital, Jilin University

AWARDS AND HONORS πŸ†

  • 2005: Top Creative Talent Award, Jilin Province
  • 2008: Young Experts with Outstanding Contributions, China Ministry of Health
  • 2009: Top Ten Famous Doctors of Jilin University
  • 2010: Special Award of State Government
  • 2011: Senior Expert Award, Jilin Province

RESEARCH FOCUS πŸ”¬

Niu Junqi’s research revolves around Hepatitis B, Hepatitis C, hepatocellular carcinoma, liver fibrosis, and cirrhosis. His work includes epidemiological studies, treatment innovations, and clinical trials targeting chronic liver diseases, particularly non-alcoholic fatty liver disease. His research significantly contributes to improving diagnostic accuracy, disease management, and therapeutic strategies in hepatology.

PUBLICATION TOP NOTES πŸ“‘

  • Activation of immune checkpoint OX40 inhibits HBV replication in a mouse model
  • Role of Early On-Treatment Serum HBV RNA Declines in Predicting Hepatocellular Carcinoma Risk
  • Safety, Pharmacokinetics, and Antiviral Efficacy of Capsid Assembly Modulator Freethiadine
  • Diammonium Glycyrrhizinate Ameliorates Alcohol-Induced Liver Injury
  • Safety, Pharmacokinetics, and Antiviral Efficacy of GST-HG141 in Chronic Hepatitis B Patients
  • ELISA Genotyping of Hepatitis B Virus in China with Antibodies for Genotypes B and C
  • Exosomes Target HBV-Host Interactions to Remodel the Hepatic Immune Microenvironment
  • TIR8 Protects Against Nonalcoholic Steatohepatitis by Reducing Lipotoxicity and Inflammation
  • High-Accuracy Model for HBsAg Loss in Long-Term Antiviral Therapy
  • System Analysis Identifies SOX7 as a Regulator of Hepatic Stellate Cell Activation

CONCLUSION

Niu Junqi is a leading expert in hepatology, with vast contributions to Hepatitis B & C research, liver disease treatment, and clinical trials. His pioneering work in liver fibrosis and hepatocellular carcinoma continues to shape the field, advancing both diagnosis and therapeutic strategies. With numerous awards, extensive experience, and impactful research, he remains a key figure in infectious disease and hepatology studies.

Mona Eldeeb | Clinical Pathology | Best Researcher Award

Prof. Dr Mona Eldeeb | Clinical Pathology | Best Researcher Award

Professor, Collage of Applied Medical Sciences – Aljouf University, Saudi Arabia

Dr. Mona K. El-Deeb is a distinguished Professor of Chemical Pathology at Alexandria University, Egypt. She has dedicated her career to advancing the fields of clinical chemistry, molecular diagnostics, and genetics. Dr. El-Deeb is a prolific researcher, contributing valuable insights into diabetes, cancer, hepatitis, and other diseases. She is actively involved in teaching and mentoring MD and Master’s students, while also serving on several accreditation, infection control, and quality assurance committees. Her work has earned her recognition as an expert in both clinical and academic settings.

PROFILE

Google Scholar

Orcid

Scopus

STRENGTHS FOR THE AWARDS

  1. Impressive Academic and Professional Background: Dr. Eldeeb’s long-standing educational and professional development in chemical pathology and molecular diagnostics, as well as her promotions, reflect her commitment and expertise. She has earned several advanced degrees from Alexandria University and has continuously progressed to higher positions, showing both leadership and in-depth knowledge in her field.
  2. Extensive Research Contributions: Dr. Eldeeb has published numerous research articles in prestigious journals on a wide range of diseases, including diabetes, breast cancer, and viral infections. She is well-versed in molecular diagnostics and clinical chemistry, demonstrating advanced research methodologies such as PCR, ELISA, sequencing, and gene expression analysis. Her research contributions have had significant impact, as shown by the citations and journal inclusions.
  3. Academic Leadership: She has supervised master’s and MD students and been involved in teaching and training future professionals in her department. Her involvement in accreditation teams, internal auditing, and quality control demonstrates her commitment to maintaining high standards in both academic and clinical settings.
  4. Collaboration with National and International Institutions: Dr. Eldeeb has worked on various collaborative research projects and actively participated in committees focused on infection control, lab safety, and accreditation. This speaks to her active role in advancing her institution’s standards.
  5. Prolific Publication Record: Her contributions span a range of complex research topics, including gene polymorphisms, oxidative stress, and molecular mechanisms underlying various diseases, indicating her high-level expertise and broad scope of influence.

AREAS FOR IMPROVEMENT

  1. Wider International Collaborations: While she has made significant contributions in Egypt, extending her collaboration on international research projects could further increase her global presence and influence.
  2. Public Outreach and Dissemination: While Dr. Eldeeb has contributed extensively to academic journals, a broader public engagement with her findings (e.g., through conferences or online platforms) could enhance the accessibility and impact of her research to a wider audience.
  3. Innovation in Research Techniques: Though she has used advanced methodologies, incorporating newer techniques in genetic and molecular diagnostics could further solidify her position as a leader in the field.

EDUCATION

πŸŽ“ MB ChB (Honor Degree) – Alexandria University, 1996
πŸŽ“ Master’s Degree in Chemical Pathology (Excellent Grade) – Alexandria University, 2002
πŸŽ“ Medical Doctor Degree in Chemical Pathology – Alexandria University, 2010
πŸŽ“ Blood Banking Diploma – Alexandria University, 2018

EXPERIENCE

πŸ’Ό Professor – Chemical Pathology Department, Alexandria University (2022–Present)
πŸ’Ό Assistant Professor – Chemical Pathology Department (2016–2022)
πŸ’Ό Lecturer – Chemical Pathology Department (2010–2016)
πŸ’Ό Assistant Lecturer – Chemical Pathology Department (2006–2010)
πŸ’Ό Resident and Trainer – Chemical Pathology Department (1999–2006)

AWARDS AND HONORS

πŸ† Participated in Chemical Pathology Department Accreditation
πŸ† Member of the Infection Control Committee
πŸ† Member of the Quality Unit, involved in internal audits
πŸ† Supervised award-winning research on molecular diagnostics and public health
πŸ† Published widely in international peer-reviewed journals

RESEARCH FOCUS

πŸ”¬ Clinical Chemistry and Molecular Diagnostics
πŸ”¬ Genetic Polymorphisms and Disease Susceptibility
πŸ”¬ Biomarkers in Cancer, Diabetes, and Infectious Diseases
πŸ”¬ Epigenetic Studies and Gene Expression Analysis
πŸ”¬ Techniques: PCR (Conventional and Real-Time), ELISA, Chemiluminescence

PUBLICATION TOP NOTES

πŸ“š Glutathione S-transferase M1, T1, and P1 Gene Polymorphisms and the Risk of Type 2 Diabetes Mellitus
πŸ“š The Role of Serum Trace Elements and Oxidative Stress in Egyptian Breast Cancer Patients
πŸ“š Effect of Weight Loss Programs on Serum Adiponectin and Insulin Resistance
πŸ“š The Effect of Multimodal Balanced Anesthesia on Neuropathic Pain Following Breast Surgery
πŸ“š Possible Association of Ghrelin/Obestatin Balance with Cardiometabolic Risk in Obese Subjects
πŸ“š The Role of Interleukin-18 and Oxidative Stress in Breast Cancer Progression
πŸ“š Study of Dickkopf-1 in Patients with Hepatitis C-Related Liver Cirrhosis
πŸ“š Aldose Reductase Gene Polymorphism and Macrovascular Complications in Diabetic Patients
πŸ“š Diagnostic Utility of Urinary Lipoarabinomannan in Pulmonary Tuberculosis
πŸ“š Genetic Polymorphisms and Gene Expression in Breast Cancer
πŸ“š Vitamin D Receptor Gene Polymorphisms in Egyptian Type 2 Diabetes Patients
πŸ“š SNP and Polymorphism in HMOX-1 Promoter Gene Associated with COVID-19 Mortality

CONCLUSION

Dr. Mona K. Eldeeb’s qualifications, extensive research, teaching leadership, and active participation in institutional improvements make her a strong contender for the Best Researcher Award. Her impressive publication record and contributions to clinical research, particularly in the field of molecular diagnostics, have had a profound impact. By continuing to expand her international collaborations and enhancing the public dissemination of her findings, Dr. Eldeeb could further solidify her legacy in the scientific community.